Inhibition of in vivo proliferation of androgen-independent prostate cancers by an antagonist of growth hormone-releasing hormone.

Por Jungwirth, A., Schally, A. V., Pinski, J., Halmos, G., Groot, K., Armatis, P., Vadillo-Buenfil, M.
Publicado em 1997

Cytotoxic analogs of luteinizing hormone-releasing hormone containing doxorubicin or 2-pyrrolinodoxorubicin, a derivative 500-1000 times more potent.

Por Nagy, A, Schally, A V, Armatis, P, Szepeshazi, K, Halmos, G, Kovacs, M, Zarandi, M, Groot, K, Miyazaki, M, Jungwirth, A, Horvath, J
Publicado em 1996

Blockade of swelling-induced chloride channels by phenol derivatives.

Por Gschwentner, M., Jungwirth, A., Hofer, S., Wöll, E., Ritter, M., Susanna, A., Schmarda, A., Reibnegger, G., Pinggera, G. M., Leitinger, M., Frick, J., Deetjen, P., Paulmichl, M.
Publicado em 1996